COVID-19

Microscopic view of the COVID-19 virus

NIBIB's goal is to accelerate research, translation, and commercialization of technologies that will provide solutions to the COVID-19 pandemic.

NIBIB is overseeing the Rapid Acceleration of Diagnostic Technologies (RADx℠ Tech) program, a $500 million effort to significantly increase testing capacity and accessibility for SARS-CoV-2, the virus that causes COVID-19. In addition to this major effort, NIBIB is supporting several areas of technology development outlined in three Notices of Special Interest (NOSIs).

Computer keyboard with a key called apply now

RADx-RAD FOAs
RFA-OD-017
RFA-OD-20-020
RFA-OD-20-021

RADx UP NOSIs For Current Grantees:
NOT-OD-20-119
NOT-OD-20-120

gloved hand holding a plastic test panel

Information about NIBIB’s effort to increase diagnostic testing capacity for SARS-CoV-2.

RADx℠ Tech Program FAQs

NOSI FAQs for Researchers/Applicants

NIBIB’s Dr. Kaitlyn Sadtler is a study lead and Principal Investigator working with NIH colleagues to test people who were infected with SARS-CoV-2 and developed antibodies but did not develop symptoms. Read more about the study.

RADx℠ Tech aims to bring accurate and easy-to-use COVID diagnostic tests to all Americans. NIBIB’s Point of Care Technologies Research Network, or POCTRN is one of the tools in NIH’s plan to accomplish this goal.

Transcripts for the video can be found on YouTube.